The U.S. Preventive Services Task Force’s latest draft recommendation on breast cancer screening is based in part on data on racial disparities in breast cancer mortality.
Oncologist Kaitlyn O’Keefe has joined Oncology Specialists of Charlotte.
USPSTF’s Wanda Nicholson: Screening saves lives, but screening alone won’t fix disparities in cancer deaths
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Jack Cuzick will receive the William L. McGuire Memorial Lecture Award at the 2023 San Antonio Breast Cancer Symposium Dec. 5-9 at the Henry B. Gonzalez Convention Center in San Antonio.
Mehran Habibi was named director of breast surgery for Staten Island University Hospital and chief of breast surgery for Northwell Health system’s Western Region, which includes Staten Island, Manhattan, and Westchester County. He will also serve as director of international program development for the Northwell Cancer Institute.
Patient-reported outcomes data from the phase III NATALEE trial, presented at the European Society for Medical Oncology Virtual Plenary, show that a broad population of patients with stage 2 and 3 hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer maintained health-related quality of life during treatment with Kisqali (ribociclib) plus endocrine therapy.
ChristianaCare received a $1 million gift from the Bacchieri Family to support the purchase of a state-of-the-art radiography system to analyze breast cancer specimens at the Helen F. Graham Cancer Center & Research Institute and expand a fellowship program to reduce disparities in breast and lung cancer.
The Medicaid expansion under the Patient Protection and Affordable Care Act resulted in a 19% annual increase in Medicaid-insured cancer patients participating in publicly funded clinical trials, according to researchers from Fred Hutchinson Cancer Center, the SWOG Statistics and Data Management Center and Columbia University.
